Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Monday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE opened at $0.00 on Monday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.05. The firm has a market cap of $681.00, a price-to-earnings ratio of 0.00 and a beta of 3.77.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.